RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 90 filers reported holding RELMADA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $223,398 | -97.2% | 64,011 | -70.4% | 0.02% | -97.0% |
| Q3 2022 | $8,013,000 | -60.4% | 216,441 | -79.7% | 0.77% | -60.8% |
| Q2 2022 | $20,260,000 | -35.5% | 1,066,854 | -8.4% | 1.96% | -35.3% |
| Q1 2022 | $31,426,000 | +831.4% | 1,164,361 | +677.4% | 3.02% | +888.6% |
| Q4 2021 | $3,374,000 | -19.4% | 149,774 | -6.2% | 0.31% | +54.5% |
| Q3 2021 | $4,184,000 | -19.1% | 159,633 | -7.8% | 0.20% | -26.7% |
| Q2 2021 | $5,175,000 | -12.0% | 173,133 | +3.7% | 0.27% | -33.2% |
| Q1 2021 | $5,878,000 | – | 166,942 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,270,072 | $61,269,000 | 9.93% |
| GREAT POINT PARTNERS LLC | 790,000 | $21,322,000 | 5.15% |
| ACUTA CAPITAL PARTNERS, LLC | 342,000 | $9,231,000 | 4.31% |
| COWEN AND COMPANY, LLC | 1,164,361 | $31,426,000 | 3.02% |
| Altium Capital Management LP | 206,000 | $5,560,000 | 1.86% |
| BVF INC/IL | 1,647,400 | $44,463,000 | 1.78% |
| RTW INVESTMENTS, LP | 2,540,074 | $68,557,000 | 1.42% |
| Vivo Capital, LLC | 705,882 | $19,052,000 | 1.31% |
| RA Capital Management | 2,000,000 | $53,980,000 | 1.18% |
| SPHERA FUNDS MANAGEMENT LTD. | 291,252 | $7,861,000 | 1.11% |